Role of Cardiac Energetics in Aortic Stenosis Disease Progression: Identifying the High-risk Metabolic Phenotype.
Monga S. et al, (2023), Circ Cardiovasc Imaging, 16
Assessment of Cardiac Energy Metabolism, Function, and Physiology in Patients With Heart Failure Taking Empagliflozin: The Randomized, Controlled EMPA-VISION Trial.
Hundertmark MJ. et al, (2023), Circulation, 147, 1654 - 1669
MODIFIED FRAILITY INDEX AS PREDICTOR OF OUTCOME FOR PATIENTS IMPLANTED WITH CARDIAC RESYNCHRONISATION
Monga S. et al, (2017), HEART, 103, A15 - A15
UPGRADE TO DEFIBRILLATOR IN PATIENTS RECEIVING CARDIAC RESYNCHRONISATION THERAPY PACEMAKERS
Monga S. et al, (2017), HEART, 103, A14 - A15
An unusual complication during implantation of an internal cardioverter-defibrillator: A Case Report
Monga S. et al, (2017), Current Research: Cardiology, 04
Mortality in patients implanted with cardiac resynchronisation therapy with or without a defibrillator
Monga S. et al, (2016), EUROPEAN JOURNAL OF HEART FAILURE, 18, 308 - 308
Tools and Techniques - Clinical. Update on coronary guidewires 2016: chronic total occlusions.
Green P. et al, (2016), EuroIntervention, 11, 1077 - 1079